127 related articles for article (PubMed ID: 27433889)
1. Intralymphatic CD30+ T-cell proliferation during DRESS: a mimic of intravascular lymphoma.
Weingertner N; Mitcov M; Chenard MP; Cribier B
J Cutan Pathol; 2016 Nov; 43(11):1036-1040. PubMed ID: 27433889
[TBL] [Abstract][Full Text] [Related]
2. Benign atypical intravascular CD30+ T-cell proliferation: a recently described reactive lymphoproliferative process and simulator of intravascular lymphoma: report of a case associated with lichen sclerosus and review of the literature.
Kempf W; Keller K; John H; Dommann-Scherrer C
Am J Clin Pathol; 2014 Nov; 142(5):694-9. PubMed ID: 25319987
[TBL] [Abstract][Full Text] [Related]
3. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
[TBL] [Abstract][Full Text] [Related]
4. Intralymphatic Proliferation of T-cell Lymphoid Blasts in the Setting of Hidradenitis Suppurativa.
Calamaro P; Cerroni L
Am J Dermatopathol; 2016 Jul; 38(7):536-40. PubMed ID: 26844617
[TBL] [Abstract][Full Text] [Related]
5. Atypical intravascular CD30+ T-cell proliferation following trauma in a healthy 17-year-old male: first reported case of a potential diagnostic pitfall and literature review.
Baum CL; Stone MS; Liu V
J Cutan Pathol; 2009 Mar; 36(3):350-4. PubMed ID: 19220631
[TBL] [Abstract][Full Text] [Related]
6. Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study.
Ortonne N; Valeyrie-Allanore L; Bastuji-Garin S; Wechsler J; de Feraudy S; Duong TA; Delfau-Larue MH; Chosidow O; Wolkenstein P; Roujeau JC
Br J Dermatol; 2015 Jul; 173(1):50-8. PubMed ID: 25630796
[TBL] [Abstract][Full Text] [Related]
7. Eruption of lymphocyte recovery with atypical lymphocytes mimicking a primary cutaneous T-cell lymphoma: a series of 12 patients.
Hurabielle C; Sbidian E; Beltraminelli H; Bouchindhomme B; Chassagne-Clément C; Balme B; Bossard C; Delfau-Larue MH; Wolkenstein P; Chosidow O; Cordonnier C; Toma A; Pautas C; Ortonne N
Hum Pathol; 2018 Jan; 71():100-108. PubMed ID: 29107664
[TBL] [Abstract][Full Text] [Related]
8. Benign atypical intravascular CD30(+) T-cell proliferation: a reactive condition mimicking intravascular lymphoma.
Riveiro-Falkenbach E; Fernández-Figueras MT; Rodríguez-Peralto JL
Am J Dermatopathol; 2013 Apr; 35(2):143-50. PubMed ID: 23542715
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous CD4 positive small/medium T-cell lymphoma with high proliferation index and CD30-positive large lymphoid cells.
Zhang L; Shao H
J Cutan Pathol; 2013 Aug; 40(8):720-4. PubMed ID: 23672694
[TBL] [Abstract][Full Text] [Related]
10. A case of CD30+ nasal natural killer/T-cell lymphoma.
Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous Intravascular Hematolymphoid Entities: A Review.
Marshall EH; Brumbaugh B; Holt A; Chen ST; Hoang MP
Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611591
[TBL] [Abstract][Full Text] [Related]
12. CD30+ clonal T-cell lymphoid proliferation of the skin in a patient with hypereosinophilic syndrome.
Kempf W; Kazakov DV; Szep Z; Vanecek T
J Cutan Pathol; 2015 Feb; 42(2):130-5. PubMed ID: 25421540
[TBL] [Abstract][Full Text] [Related]
13. T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30(+) cutaneous lymphoma cells.
Hombach A; Muche JM; Gerken M; Gellrich S; Heuser C; Pohl C; Sterry W; Abken H
Gene Ther; 2001 Jun; 8(11):891-5. PubMed ID: 11423937
[TBL] [Abstract][Full Text] [Related]
14. T-cell receptor gene rearrangement and CD30 immunoreactivity in traumatic ulcerative granuloma with stromal eosinophilia of the oral cavity.
Salisbury CL; Budnick SD; Li S
Am J Clin Pathol; 2009 Nov; 132(5):722-7. PubMed ID: 19846813
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous intravascular CD30+ T-cell pseudolymphoma occurring in a regressing keratoacanthoma.
Kailas A; Elston DM; Crater SE; Cerruto CA
J Cutan Pathol; 2018 Apr; 45(4):296-298. PubMed ID: 29369392
[TBL] [Abstract][Full Text] [Related]
16. Intralymphatic atypical T-cell proliferation in a cutaneous hemangioma.
Ardighieri L; Lonardi S; Vermi W; Medicina D; Cerroni L; Facchetti F
J Cutan Pathol; 2010 Apr; 37(4):497-503. PubMed ID: 19614995
[TBL] [Abstract][Full Text] [Related]
17. Pagetoid reticulosis with CD30 positivity and cytotoxic/suppressor cells.
Jacyk WK; Grayson W; Dinkel JE; Requena L
J Cutan Pathol; 2007 Aug; 34(8):644-7. PubMed ID: 17640236
[TBL] [Abstract][Full Text] [Related]
18. T cell receptor-gamma gene analysis of CD30+ large atypical individual cells in CD30+ large primary cutaneous T cell lymphomas.
Gellrich S; Wilks A; Lukowsky A; Wernicke M; Müller A; Marcus Muche J; Fischer T; Jasch KC; Audring H; Sterry W
J Invest Dermatol; 2003 Apr; 120(4):670-5. PubMed ID: 12648233
[TBL] [Abstract][Full Text] [Related]
19. Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding.
Al-Rohil RN; Torres-Cabala CA; Patel A; Tetzlaff MT; Ivan D; Nagarajan P; Curry JL; Miranda RN; Duvic M; Prieto VG; Aung PP
J Cutan Pathol; 2016 Dec; 43(12):1161-1166. PubMed ID: 27531242
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.
Hagiwara M; Tomita A; Takata K; Shimoyama Y; Yoshino T; Tomita Y; Nakamura S
Pathol Int; 2012 Apr; 62(4):264-70. PubMed ID: 22449230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]